Biocompatibility

 Biocompatibility is defined as “ability of a medical device or material to perform with an appropriate host response in a specific application”.

The following information shall be considered for evaluating the overall biological evaluation of the medical device:

• a) Direct and indirect tissue contacting materials
• b) Additives, process contaminants and residues
• c) Packaging materials
• d) Leachable substances
• e) Degradation products
• f) Performance and physical characteristics of the final product

 Biological evaluation is determined based on nature, degree, frequency and duration of the exposure and the hazards identified for the medical device or material.

 Step 1: Identify the category of medical devices.

This helps for selection of appropriate tests relevant for medical devices. 

Categorization by nature of body contact	Categorization by duration of contact
Non-contacting medical devices Surface-contacting medical devices Skin,Mucosal membrane ,Breached or compromised surfaces Externally communicating medical devices Blood path, indirect, Tissue/bone/dentin, Circulating blood Implant medical devices Tissue/bone, Blood	Limited exposure (A) – duration of contact is up to 24 h.   Prolonged exposure (B) – contact time is likely to exceed 24 h but not exceed 30 days.   Long-term exposure (C) –contact time exceeds 30 days

 

• Transitory-contacting medical devices have limited exposure (A) and these devices does not require testing to address biocompatibility. But for products made with materials such as coatings or lubricants needs testing.
• Medical devices with multiple contact duration categories require more rigorous testing and/or evaluation considerations shall apply.

 

Step 2: Conduct a physical and/or chemical characterization per ISO 10993-18.

 If the materials, chemicals and processes has an established history of safe use in

the intended application and physical properties have not changed, then no further testing required and rationale shall be documented.

 further testing need not be required if the device extractables and leachables have sufficient toxicological data relevant to the expected exposure (quantity, route and frequency)

 Step 3: Conduct the biological testing (source ISO 10993:2018)

 

S.No	Testing	Type of Devices to be tested	Categorization by nature of body contact	Categorization by duration of contact
1	Physical and/or chemical information	All medical device categories	all types of contact	all durations of contact
2	Irritation or intracutaneous reactivity	externally communicating medical devices	indirect blood path contact	long term duration
3	Material mediated pyrogenicity and acute systemic toxicity	medical devices with breached or compromised surface contact		all durations of contact
4	Material mediated pyrogenicity	externally communicating medical devices and implant medical devices	all types of contact	all durations of contact
5	Acute systemic toxicity	surface medical devices	mucosal membrane contact	prolonged or long-term contact
		externally communicating medical devices	tissue/ bone/dentin contact	limited duration
		implant medical devices	tissue/bone contact	limited duration
6	Subacute toxicity	all medical device types		prolonged and long term contact
7	Subchronic and chronic toxicity	all medical device types		long term contact
8	Implantation effects	surface medical devices	mucosal membrane contact	prolonged or long term contact
		surface medical devices	breached or compromised surface contact	prolonged or long term contact
		externally communicating medical devices	indirect blood path contact	long term duration
9	Genotoxicity	externally communicating medical devices	circulating blood contact	limited duration
10		implant medical devices	blood contact	limited duration
11	Carcinogenicity	surface medical devices	breached or compromised surface contact	long term duration
12		externally communicating medical devices	all types of contact	long term duration
13		implant medical devices	all types of contact	long term duration

 

For US FDA regulatory submission please use the US FDA guidance document “Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process"